For instance, in a study conducted on 50 MS patients and 21 healthy controls, 20 patients received DMTs (IFN‐β1 or TER), 19 patients received DMTs in conjunction with homeopathy, while 11 patients accepted solely homeopathy. This evidence concerns the gene IFNB1 and myeloid sarcoma.